Physician profile
Dikran Torian
NPI 1396790861
$3,134.23
in general payments reported to CMS, 2019-2025
16 companies · $1,549 in 2025
The $1,549 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2021: $158 · 2022: $243 · 2023: $465 · 2024: $435 · 2025: $1,549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,430 · Travel and Lodging: $1,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,429.57 |
| Travel and Lodging | $1,018.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,245.08 | 2025 | Senza |
| Curonix LLC | $594.67 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $269.91 | 2019-2022 | |
| Painteq LLC | $162.36 | 2024 | Painteq |
| Si-Bone, INC. | $153.24 | 2024 | |
| Abbvie INC. | $125.00 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $123.87 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $123.76 | 2021 | |
| Nevro Corp. | $122.25 | 2019-2024 | Senza |
| Spr Therapeutics, INC | $73.31 | 2024 | Sprint Pns System |
| Lundbeck LLC | $33.83 | 2025 | Vyepti |
| Neuronetics, INC. | $31.88 | 2022 | |
| Stryker Corporation | $24.27 | 2024 | |
| Abbott Laboratories | $18.57 | 2022 | |
| Trevena, INC. | $17.30 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $14.93 | 2025 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dikran Torian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.